Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An immunodeficiency associated with increased susceptibility to invasive infections caused by pyogenic bacteria.
Features include always present findings: Meningitis, Complete or near-complete absence of specific antibody response to unconjugated pneumococcus vaccine, Recurrent streptococcal infections, and Septic arthritis and others; and common findings: Increased circulating IgE concentration and Liver abscess. 12 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 4 | Transiently decreased total neutrophil count, Recurrent streptococcal infections, Recurrent staphylococcal infections |
IRAK4 encodes interleukin 1 receptor associated kinase 4 (460 aa). Serine/threonine-protein kinase that plays a critical role in initiating innate immune response against foreign pathogens. Involved in Toll-like receptor (TLR) and IL-1R signaling pathways. Highest expression in Spleen (29.7 TPM) and Cells EBV-transformed lymphocytes (22.7 TPM).
Immunodeficiency 67 is associated with mutations in the IRAK4 gene on chromosome 12.
The IRAK4 protein participates in p-2S,S376,T,T209,T387-IRAK1, IRAK4 pathway.
IRAK4 is classified as a druggable target (Cell Surface, Druggable Genome, Enzyme, Kinase, and Serine Threonine Kinase categories) with score 2.4.
Genetic testing for IRAK4 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 5 always present features, 2 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for immunodeficiency 67.
9 publications have been identified in PubMed for immunodeficiency 67. Research spans Case Report / Case Series (56%), Epidemiology / Natural History (22%), and Review / Meta-Analysis (11%).
Zhang J (2026). [PMID: 42103176](https://pubmed.ncbi.nlm.nih.gov/42103176/). *Gene*. [Basic Science / Preclinical]
Lin Y (2025). [PMID: 41233127](https://pubmed.ncbi.nlm.nih.gov/41233127/). *Zhonghua er ke za zhi = Chinese journal of pediatrics*. [Case Report / Case Series]
Kindle G (2025). [PMID: 40568655](https://pubmed.ncbi.nlm.nih.gov/40568655/). *medRxiv : the preprint server for health sciences*. [Epidemiology / Natural History]
Jurczuk A (2025). [PMID: 41369391](https://pubmed.ncbi.nlm.nih.gov/41369391/). *Cells*. [Review / Meta-Analysis]
Kindle G (2025). [PMID: 41347188](https://pubmed.ncbi.nlm.nih.gov/41347188/). *Journal of human immunity*. [Epidemiology / Natural History]
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 12:11 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Lab test results | 2 | Increased circulating IgE concentration, Complete or near-complete absence of specific antibody response to unconjugated pneumococcus vaccine |
Brain and nerves | 1 | Meningitis |
Lungs and breathing | 1 | Complete or near-complete absence of specific antibody response to unconjugated pneumococcus vaccine |
Bones and joints | 1 | Septic arthritis |
Digestive system | 1 | Liver abscess |
Sacta MA (2024). [PMID: 38758474](https://pubmed.ncbi.nlm.nih.gov/38758474/). *Journal of clinical immunology*. [Case Report / Case Series]
Turkyilmaz Ucar O (2024). [PMID: 38857180](https://pubmed.ncbi.nlm.nih.gov/38857180/). *Journal of pediatric hematology/oncology*. [Case Report / Case Series]
Zhang F (2024). [PMID: 38838930](https://pubmed.ncbi.nlm.nih.gov/38838930/). *Clinical immunology (Orlando, Fla.)*. [Case Report / Case Series]